Betsy Bombick
Papers
1
Total Citations
10
H-Index
1
About
Dr. Betsy Bombick is a leading toxicologist specializing in the in vitro assessment of tobacco and nicotine product aerosols, with a primary focus on advancing whole-smoke exposure methodologies. Her most cited work, "Development of a quantitative method for assessment of dose in in vitro evaluations using a VITROCELL® VC10® smoke exposure system" (2018, 10 citations), addresses a critical gap in tobacco product testing. Historically, cytotoxicity and genotoxicity evaluations relied on partitioned exposures—such as total particulate matter (TPM) or gas vapor phase (GVP)—which fail to replicate real-world inhalation. Dr. Bombick’s research established a robust, quantitative framework for delivering and measuring whole-smoke doses, enabling more physiologically relevant assessments of combustible tobacco products. This methodological innovation has been instrumental in standardizing in vitro testing protocols, directly impacting regulatory science and product safety evaluations. Her work is widely recognized for bridging the gap between laboratory models and human exposure scenarios, making her a key contributor to the field of aerosol toxicology. With a career dedicated to refining exposure systems, Dr. Bombick continues to shape best practices for evaluating next-generation nicotine delivery systems.
Research Focus
Key Achievements
Top Papers
- 1